- Home
- PHVS vs IIPR Comparison
PHVS vs IIPR Comparison
Compare PHVS & IIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- IIPR
- Stock Information
- Founded
- PHVS 2015
- IIPR 2016
- Country
- PHVS Switzerland
- IIPR United States
- Employees
- PHVS N/A
- IIPR N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- IIPR Real Estate
- Sector
- PHVS Health Care
- IIPR Finance
- Exchange
- PHVS Nasdaq
- IIPR Nasdaq
- Market Cap
- PHVS 1.6B
- IIPR 1.5B
- IPO Year
- PHVS 2021
- IIPR 2016
- Fundamental
- Price
- PHVS $22.08
- IIPR $49.63
- Analyst Decision
- PHVS Buy
- IIPR Hold
- Analyst Count
- PHVS 6
- IIPR 8
- Target Price
- PHVS $36.50
- IIPR $88.75
- AVG Volume (30 Days)
- PHVS 217.1K
- IIPR 266.2K
- Earning Date
- PHVS 11-12-2025
- IIPR 11-03-2025
- Dividend Yield
- PHVS N/A
- IIPR 14.46%
- EPS Growth
- PHVS N/A
- IIPR N/A
- EPS
- PHVS N/A
- IIPR 4.63
- Revenue
- PHVS N/A
- IIPR $287,883,000.00
- Revenue This Year
- PHVS N/A
- IIPR N/A
- Revenue Next Year
- PHVS N/A
- IIPR N/A
- P/E Ratio
- PHVS N/A
- IIPR $11.34
- Revenue Growth
- PHVS N/A
- IIPR N/A
- 52 Week Low
- PHVS $11.51
- IIPR $45.44
- 52 Week High
- PHVS $26.33
- IIPR $135.78
- Technical
- Relative Strength Index (RSI)
- PHVS 49.23
- IIPR 41.96
- Support Level
- PHVS $22.38
- IIPR $52.55
- Resistance Level
- PHVS $23.64
- IIPR $55.19
- Average True Range (ATR)
- PHVS 1.28
- IIPR 1.42
- MACD
- PHVS 0.04
- IIPR -0.16
- Stochastic Oscillator
- PHVS 61.27
- IIPR 15.99
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About IIPR Innovative Industrial Properties Inc.
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.